Coenzyme Q10 (CoQ10) In Isolated Diastolic Heart Failure In Hypertrophic Cardiomyopathy (HCM)
| Effect | Decrease |
| Trial Design | Cohort |
| Trial Length | 6+ Months |
| Number of Subjects | 41 |
| Sex | Both Genders |
| Age Range | 18-29, 30-44, 45-64, 65+ |
200mg CoQ10 daily alongside standard therapy (same in both groups) in persons with cardiohypertrophy was able to improve left ventricle and heart function while reducing the size of the left ventricle. Time of trial varied (9.4-27.5 months, mean length over a year)
